2022 Q1 Form 10-Q Financial Statement

#000079923322000022 Filed on May 09, 2022

View on sec.gov

Income Statement

Concept 2022 Q1 2021 Q1
Revenue $151.3M $152.4M
YoY Change -0.72% -8.36%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $104.0M $105.9M
YoY Change -1.77% -8.07%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $23.31M $26.98M
YoY Change -13.61% 0.83%
% of Gross Profit
Operating Expenses $133.1M $138.3M
YoY Change -3.73% -7.06%
Operating Profit $22.40M $18.28M
YoY Change 22.52% 5.5%
Interest Expense $146.0K $100.0K
YoY Change 46.0% -75.0%
% of Operating Profit 0.65% 0.55%
Other Income/Expense, Net
YoY Change
Pretax Income $22.54M $18.42M
YoY Change 22.39% 4.03%
Income Tax $5.766M $4.683M
% Of Pretax Income 25.58% 25.43%
Net Earnings $16.78M $13.73M
YoY Change 22.14% 3.75%
Net Earnings / Revenue 11.09% 9.01%
Basic Earnings Per Share $0.21 $0.17
Diluted Earnings Per Share $0.21 $0.17
COMMON SHARES
Basic Shares Outstanding 78.93M shares 80.15M shares
Diluted Shares Outstanding 78.95M shares 80.21M shares

Balance Sheet

Concept 2022 Q1 2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $187.1M $148.2M
YoY Change 26.24% 130.84%
Cash & Equivalents $187.1M $148.2M
Short-Term Investments
Other Short-Term Assets $9.776M $9.129M
YoY Change 7.09% -16.98%
Inventory
Prepaid Expenses
Receivables $61.58M $60.57M
Other Receivables $0.00 $0.00
Total Short-Term Assets $268.5M $226.7M
YoY Change 18.45% 51.86%
LONG-TERM ASSETS
Property, Plant & Equipment $472.0M $512.8M
YoY Change -7.97% -6.03%
Goodwill $168.3M $168.3M
YoY Change 0.0% 0.0%
Intangibles $21.76M $24.15M
YoY Change -9.9% -9.01%
Long-Term Investments
YoY Change
Other Assets $16.59M $17.48M
YoY Change -5.06% -3.88%
Total Long-Term Assets $678.6M $722.8M
YoY Change -6.11% -5.4%
TOTAL ASSETS
Total Short-Term Assets $268.5M $226.7M
Total Long-Term Assets $678.6M $722.8M
Total Assets $947.1M $949.4M
YoY Change -0.24% 3.96%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $20.28M $17.00M
YoY Change 19.28% -6.08%
Accrued Expenses $53.81M $60.10M
YoY Change -10.46% 12.13%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $77.54M $84.06M
YoY Change -7.75% 17.2%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $38.82M $50.50M
YoY Change -23.14% -10.46%
Total Long-Term Liabilities $127.0M $142.9M
YoY Change -11.13% -8.88%
TOTAL LIABILITIES
Total Short-Term Liabilities $77.54M $84.06M
Total Long-Term Liabilities $127.0M $142.9M
Total Liabilities $204.6M $227.0M
YoY Change -9.88% -0.7%
SHAREHOLDERS EQUITY
Retained Earnings $939.6M $903.1M
YoY Change 4.04% 7.73%
Common Stock $5.112M $5.383M
YoY Change -5.03% 0.82%
Preferred Stock
YoY Change
Treasury Stock (at cost) $202.2M $186.1M
YoY Change 8.64% 17.08%
Treasury Stock Shares 11.76M shares 10.78M shares
Shareholders Equity $742.5M $722.4M
YoY Change
Total Liabilities & Shareholders Equity $947.1M $949.4M
YoY Change -0.24% 3.96%

Cashflow Statement

Concept 2022 Q1 2021 Q1
OPERATING ACTIVITIES
Net Income $16.78M $13.73M
YoY Change 22.14% 3.75%
Depreciation, Depletion And Amortization $23.31M $26.98M
YoY Change -13.61% 0.83%
Cash From Operating Activities $37.59M $35.43M
YoY Change 6.1% -11.55%
INVESTING ACTIVITIES
Capital Expenditures $22.03M $9.750M
YoY Change 125.94% -76.84%
Acquisitions
YoY Change
Other Investing Activities $0.00 -$78.00K
YoY Change -100.0% 52.94%
Cash From Investing Activities -$8.381M $15.48M
YoY Change -154.14% -139.06%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00 $15.02M
YoY Change -100.0% 22.35%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -$41.00K -$16.72M
YoY Change -99.75% 18.18%
NET CHANGE
Cash From Operating Activities $37.59M $35.43M
Cash From Investing Activities -$8.381M $15.48M
Cash From Financing Activities -$41.00K -$16.72M
Net Change In Cash $29.17M $34.20M
YoY Change -14.69% -349.23%
FREE CASH FLOW
Cash From Operating Activities $37.59M $35.43M
Capital Expenditures $22.03M $9.750M
Free Cash Flow $15.56M $25.68M
YoY Change -39.4% -1362.01%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q1 dei Entity Registrant Name
EntityRegistrantName
HEARTLAND EXPRESS INC
CY2022Q1 dei Entity Central Index Key
EntityCentralIndexKey
0000799233
CY2022Q1 dei Amendment Flag
AmendmentFlag
false
CY2022Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2022Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2022Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2022Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
78933450 shares
CY2022Q1 dei Entity Shell Company
EntityShellCompany
false
CY2022Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2022Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2022Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1100000 USD
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1100000 USD
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
90689000 shares
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
78932000 shares
CY2022Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2022Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
395000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
395000000 shares
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
90689000 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
78923000 shares
CY2022Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
11757000 shares
CY2021Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
11766000 shares
CY2022Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.02
CY2021Q1 htld Restricted Cash And Investments Current Total
RestrictedCashAndInvestmentsCurrentTotal
1000000 USD
CY2021Q1 htld Restricted Cash And Cash Equivalents Non Current
RestrictedCashAndCashEquivalentsNonCurrent
16100000 USD
CY2022Q1 us-gaap Finitelived Intangible Assets Acquired1
FinitelivedIntangibleAssetsAcquired1
0 USD
CY2021Q4 us-gaap Line Of Credit
LineOfCredit
0 USD
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
0 USD
CY2022Q1 us-gaap Unrecognized Tax Benefits Period Increase Decrease
UnrecognizedTaxBenefitsPeriodIncreaseDecrease
200000 USD
CY2022Q1 dei Document Type
DocumentType
10-Q
CY2022Q1 dei Document Period End Date
DocumentPeriodEndDate
2022-03-31
CY2022Q1 dei Entity File Number
EntityFileNumber
0-15087
CY2022Q1 dei Entity Registrant Name
EntityRegistrantName
HEARTLAND EXPRESS INC
CY2022Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2022Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
93-0926999
CY2022Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
901 Heartland Way,
CY2022Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
North Liberty,
CY2022Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
IA
CY2022Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
52317
CY2022Q1 dei City Area Code
CityAreaCode
319
CY2022Q1 dei Local Phone Number
LocalPhoneNumber
645-7060
CY2022Q1 dei Security12b Title
Security12bTitle
Common Stock, $0.01 par value
CY2022Q1 dei Trading Symbol
TradingSymbol
HTLD
CY2021Q4 us-gaap Land And Land Improvements
LandAndLandImprovements
90218000 USD
CY2022Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2022Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
78933450 shares
CY2022Q1 dei Document Period End Date
DocumentPeriodEndDate
2022-03-31
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
187085000 USD
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
157742000 USD
CY2022Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
61583000 USD
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
52812000 USD
CY2022Q1 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
10043000 USD
CY2021Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
9168000 USD
CY2022Q1 us-gaap Other Assets Current
OtherAssetsCurrent
9776000 USD
CY2021Q4 us-gaap Other Assets Current
OtherAssetsCurrent
9406000 USD
CY2022Q1 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
0 USD
CY2021Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
4095000 USD
CY2022Q1 us-gaap Assets Current
AssetsCurrent
268487000 USD
CY2021Q4 us-gaap Assets Current
AssetsCurrent
233223000 USD
CY2022Q1 us-gaap Land And Land Improvements
LandAndLandImprovements
90787000 USD
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
907000 USD
CY2022Q1 us-gaap Common Stock Value
CommonStockValue
907000 USD
CY2022Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
4205000 USD
CY2022Q1 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
96685000 USD
CY2021Q4 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
95305000 USD
CY2022Q1 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
5399000 USD
CY2021Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
5365000 USD
CY2022Q1 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
17104000 USD
CY2021Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
15727000 USD
CY2022Q1 htld Revenue Equipment
RevenueEquipment
491924000 USD
CY2021Q4 htld Revenue Equipment
RevenueEquipment
500311000 USD
CY2022Q1 us-gaap Construction In Progress Gross
ConstructionInProgressGross
3732000 USD
CY2021Q4 us-gaap Construction In Progress Gross
ConstructionInProgressGross
3834000 USD
CY2022Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
705631000 USD
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
710760000 USD
CY2022Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
233652000 USD
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
222845000 USD
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
471979000 USD
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
487915000 USD
CY2022Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
24171000 USD
CY2022Q1 us-gaap Goodwill
Goodwill
168295000 USD
CY2021Q4 us-gaap Goodwill
Goodwill
168295000 USD
CY2022Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
21758000 USD
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
22355000 USD
CY2022Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
16594000 USD
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
16754000 USD
CY2022Q1 us-gaap Assets
Assets
947113000 USD
CY2021Q4 us-gaap Assets
Assets
928542000 USD
CY2022Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
20278000 USD
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
20538000 USD
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
21411000 USD
CY2022Q1 us-gaap Self Insurance Reserve Current
SelfInsuranceReserveCurrent
15248000 USD
CY2021Q4 us-gaap Self Insurance Reserve Current
SelfInsuranceReserveCurrent
15677000 USD
CY2022Q1 us-gaap Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
14394000 USD
CY2021Q4 us-gaap Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
13968000 USD
CY2022Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
3452000 USD
CY2021Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
0 USD
CY2022Q1 us-gaap Liabilities Current
LiabilitiesCurrent
77543000 USD
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
71594000 USD
CY2022Q1 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
5313000 USD
CY2021Q4 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
5491000 USD
CY2022Q1 us-gaap Deferred Tax And Other Liabilities Noncurrent
DeferredTaxAndOtherLiabilitiesNoncurrent
88227000 USD
CY2021Q4 us-gaap Deferred Tax And Other Liabilities Noncurrent
DeferredTaxAndOtherLiabilitiesNoncurrent
89971000 USD
CY2022Q1 us-gaap Self Insurance Reserve Noncurrent
SelfInsuranceReserveNoncurrent
33502000 USD
CY2021Q4 us-gaap Self Insurance Reserve Noncurrent
SelfInsuranceReserveNoncurrent
34384000 USD
CY2022Q1 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
127042000 USD
CY2021Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
129846000 USD
CY2022Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2022Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2021Q1 us-gaap Revenues
Revenues
152402000 USD
CY2022Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
58638000 USD
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
4141000 USD
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
939571000 USD
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
924375000 USD
CY2022Q1 us-gaap Treasury Stock Value
TreasuryStockValue
202155000 USD
CY2021Q4 us-gaap Treasury Stock Value
TreasuryStockValue
202321000 USD
CY2022Q1 htld Stockholders Equity Attributable To Parent2
StockholdersEquityAttributableToParent2
742528000 USD
CY2021Q4 htld Stockholders Equity Attributable To Parent2
StockholdersEquityAttributableToParent2
727102000 USD
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
947113000 USD
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
928542000 USD
CY2022Q1 us-gaap Revenues
Revenues
151275000 USD
CY2021Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
64782000 USD
CY2022Q1 htld Rent And Purchased Transportation
RentAndPurchasedTransportation
748000 USD
CY2021Q1 htld Rent And Purchased Transportation
RentAndPurchasedTransportation
964000 USD
CY2022Q1 us-gaap Fuel Costs
FuelCosts
29711000 USD
CY2021Q1 us-gaap Fuel Costs
FuelCosts
24157000 USD
CY2022Q1 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
5079000 USD
CY2021Q1 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
5688000 USD
CY2022Q1 us-gaap Direct Taxes And Licenses Costs
DirectTaxesAndLicensesCosts
3209000 USD
CY2021Q1 us-gaap Direct Taxes And Licenses Costs
DirectTaxesAndLicensesCosts
3621000 USD
CY2022Q1 us-gaap Operating Insurance And Claims Costs Production
OperatingInsuranceAndClaimsCostsProduction
5566000 USD
CY2021Q1 us-gaap Operating Insurance And Claims Costs Production
OperatingInsuranceAndClaimsCostsProduction
5439000 USD
CY2022Q1 us-gaap Direct Communications And Utilities Costs
DirectCommunicationsAndUtilitiesCosts
1078000 USD
CY2021Q1 us-gaap Direct Communications And Utilities Costs
DirectCommunicationsAndUtilitiesCosts
1226000 USD
CY2022Q1 htld Depreciationandamortizationexcludingdepreciationoncommunicationequipment
Depreciationandamortizationexcludingdepreciationoncommunicationequipment
23311000 USD
CY2021Q1 htld Depreciationandamortizationexcludingdepreciationoncommunicationequipment
Depreciationandamortizationexcludingdepreciationoncommunicationequipment
26926000 USD
CY2022Q1 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
5798000 USD
CY2021Q1 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
5552000 USD
CY2022Q1 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
4258000 USD
CY2021Q1 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
4232000 USD
CY2022Q1 us-gaap Costs And Expenses
CostsAndExpenses
128880000 USD
CY2021Q1 us-gaap Costs And Expenses
CostsAndExpenses
134123000 USD
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5766000 USD
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4683000 USD
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
22395000 USD
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
18279000 USD
CY2022Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
146000 USD
CY2021Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
138000 USD
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
22541000 USD
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
18417000 USD
CY2022Q1 htld Net Income
NetIncome
16775000 USD
CY2021Q1 htld Net Income
NetIncome
13734000 USD
CY2022Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
0 USD
CY2021Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
0 USD
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
16775000 USD
CY2021Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
13734000 USD
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.21
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.17
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.21
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.17
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
78929000 shares
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
80152000 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
78953000 shares
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
80206000 shares
CY2022Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.02
CY2021Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.02
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
727102000 USD
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
16775000 USD
CY2022Q1 us-gaap Dividends Common Stock
DividendsCommonStock
1579000 USD
CY2022Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-230000 USD
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
742528000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
724334000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
13734000 USD
CY2021Q1 us-gaap Dividends Common Stock
DividendsCommonStock
1599000 USD
CY2021Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
14537000 USD
CY2021Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-485000 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
722417000 USD
CY2022Q1 htld Net Income2
NetIncome2
-16775000 USD
CY2021Q1 htld Net Income2
NetIncome2
-13734000 USD
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
23311000 USD
CY2021Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
26983000 USD
CY2022Q1 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
1744000 USD
CY2021Q1 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
3390000 USD
CY2022Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
271000 USD
CY2021Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
581000 USD
CY2022Q1 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
4258000 USD
CY2021Q1 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
4232000 USD
CY2022Q1 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
8771000 USD
CY2021Q1 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
4991000 USD
CY2022Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1083000 USD
CY2021Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
25152000 USD
CY2021Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-4053000 USD
CY2022Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
3557000 USD
CY2021Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-2554000 USD
CY2022Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
7369000 USD
CY2021Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
5248000 USD
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
37593000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
35432000 USD
CY2022Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
13648000 USD
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
22029000 USD
CY2021Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
9750000 USD
CY2022Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
0 USD
CY2021Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-78000 USD
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-8381000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
15480000 USD
CY2022Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
0 USD
CY2021Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
1599000 USD
CY2022Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
41000 USD
CY2021Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
96000 USD
CY2022Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 USD
CY2021Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
15022000 USD
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-41000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-16717000 USD
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
29171000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
34195000 USD
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
173767000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
131140000 USD
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
202938000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
165335000 USD
CY2022Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
142000 USD
CY2021Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
2825000 USD
CY2022Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
2058000 USD
CY2021Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
6726000 USD
CY2022Q1 htld Soldrevenueequipmentinothercurrentassets
Soldrevenueequipmentinothercurrentassets
1213000 USD
CY2021Q1 htld Soldrevenueequipmentinothercurrentassets
Soldrevenueequipmentinothercurrentassets
212000 USD
CY2022Q1 htld Common Stock Dividends Declared In Accounts Payable
CommonStockDividendsDeclaredInAccountsPayable
1579000 USD
CY2021Q1 htld Common Stock Dividends Declared In Accounts Payable
CommonStockDividendsDeclaredInAccountsPayable
0 USD
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
187085000 USD
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
148212000 USD
CY2022Q1 us-gaap Restricted Cash And Investments Current
RestrictedCashAndInvestmentsCurrent
916000 USD
CY2021Q1 us-gaap Restricted Cash And Investments Current
RestrictedCashAndInvestmentsCurrent
1033000 USD
CY2022Q1 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
14937000 USD
CY2021Q1 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
16090000 USD
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
202938000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
165335000 USD
CY2022Q1 dei Document Period End Date
DocumentPeriodEndDate
2022-03-31
CY2022Q1 us-gaap Use Of Estimates
UseOfEstimates
Use of EstimatesThe preparation of the consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
CY2022Q1 dei Document Period End Date
DocumentPeriodEndDate
2022-03-31
CY2022Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 segments
CY2022Q1 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
1300000 USD
CY2021Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
1300000 USD
CY2022Q1 dei Document Period End Date
DocumentPeriodEndDate
2022-03-31
CY2022Q1 dei Document Period End Date
DocumentPeriodEndDate
2022-03-31
CY2022Q1 us-gaap Revenues
Revenues
151300000 USD
CY2021Q1 us-gaap Revenues
Revenues
152400000 USD
CY2022Q1 dei Document Period End Date
DocumentPeriodEndDate
2022-03-31
CY2022Q1 dei Document Period End Date
DocumentPeriodEndDate
2022-03-31
CY2022Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
3200000 USD
CY2021Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
3100000 USD
CY2022Q1 dei Document Period End Date
DocumentPeriodEndDate
2022-03-31
CY2022Q1 dei Document Period End Date
DocumentPeriodEndDate
2022-03-31
CY2022Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
15800000 USD
CY2022Q1 htld Restricted Cash And Investments Current Total
RestrictedCashAndInvestmentsCurrentTotal
900000 USD
CY2022Q1 htld Restricted Cash And Cash Equivalents Non Current
RestrictedCashAndCashEquivalentsNonCurrent
14900000 USD
CY2021Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
16000000 USD
CY2021Q4 htld Restricted Cash And Investments Current Total
RestrictedCashAndInvestmentsCurrentTotal
900000 USD
CY2021Q4 htld Restricted Cash And Cash Equivalents Non Current
RestrictedCashAndCashEquivalentsNonCurrent
15100000 USD
CY2022Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
600000 USD
CY2021Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
600000 USD
CY2022Q1 dei Document Period End Date
DocumentPeriodEndDate
2022-03-31
CY2022Q1 htld Amortization Period Of Tires
AmortizationPeriodOfTires
two years
CY2022Q1 dei Document Period End Date
DocumentPeriodEndDate
2022-03-31
CY2022Q1 htld Increase Decrease Of Restricted Cash And Investments
IncreaseDecreaseOfRestrictedCashAndInvestments
1200000 USD
CY2021 htld Increase Decrease Of Restricted Cash And Investments
IncreaseDecreaseOfRestrictedCashAndInvestments
1500000 USD
CY2022Q1 us-gaap Finitelived Intangible Assets Acquired1
FinitelivedIntangibleAssetsAcquired1
0 USD
CY2022Q1 dei Document Period End Date
DocumentPeriodEndDate
2022-03-31
CY2022Q1 dei Document Period End Date
DocumentPeriodEndDate
2022-03-31
CY2022Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
41200000 USD
CY2022Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
19442000 USD
CY2022Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
21758000 USD
CY2022Q1 dei Document Period End Date
DocumentPeriodEndDate
2022-03-31
CY2022Q1 dei Document Period End Date
DocumentPeriodEndDate
2022-03-31
CY2022Q1 dei Document Period End Date
DocumentPeriodEndDate
2022-03-31
CY2022Q1 htld Net Income Loss Eps
NetIncomeLossEPS
16775000 USD
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
78929000 shares
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.21
CY2022Q1 us-gaap Amount Of Dilutive Securities Stock Options And Restrictive Stock Units
AmountOfDilutiveSecuritiesStockOptionsAndRestrictiveStockUnits
0 USD
CY2022Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
24000 shares
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
16775000 USD
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
78953000 shares
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.21
CY2021Q1 htld Net Income Loss Eps
NetIncomeLossEPS
13734000 USD
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
80152000 shares
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.17
CY2021Q1 us-gaap Amount Of Dilutive Securities Stock Options And Restrictive Stock Units
AmountOfDilutiveSecuritiesStockOptionsAndRestrictiveStockUnits
0 USD
CY2021Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
54000 shares
CY2021Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
13734000 USD
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
80206000 shares
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.17
CY2022Q1 htld Debt Covenant Minimum Net Income Requirement
DebtCovenantMinimumNetIncomeRequirement
1.00 USD
CY2022Q1 us-gaap Stock Repurchase Program Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
6600000 shares
CY2022Q1 dei Document Period End Date
DocumentPeriodEndDate
2022-03-31
CY2022Q1 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
0 shares
CY2022Q1 dei Document Period End Date
DocumentPeriodEndDate
2022-03-31
CY2021Q1 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
800000 shares
CY2021Q1 htld Treasury Stock Value Acquired
TreasuryStockValueAcquired
14500000 USD
CY2022Q1 dei Document Period End Date
DocumentPeriodEndDate
2022-03-31
CY2022Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
1600000 USD
CY2021Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
1600000 USD
CY2011Q3 htld Restricted Stock Shares Authorized
RestrictedStockSharesAuthorized
900000 shares
CY2021Q2 htld Restricted Stock Shares Authorized
RestrictedStockSharesAuthorized
600000 shares
CY2022Q1 dei Document Period End Date
DocumentPeriodEndDate
2022-03-31
CY2022Q1 dei Document Period End Date
DocumentPeriodEndDate
2022-03-31
CY2022Q1 dei Document Period End Date
DocumentPeriodEndDate
2022-03-31
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
300000 USD
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
600000 USD
CY2022Q1 dei Document Period End Date
DocumentPeriodEndDate
2022-03-31
CY2022Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
200000 USD
CY2022Q1 dei Document Period End Date
DocumentPeriodEndDate
2022-03-31
CY2022Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y
CY2022Q1 dei Document Period End Date
DocumentPeriodEndDate
2022-03-31
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
14000.0 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
19.70
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
25000.0 shares
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
15.17
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
12000.0 shares
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
15.51
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
0 shares
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
0
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
27000.0 shares
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
17.37
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
59700 shares
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
20.29
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
19300 shares
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
18.69
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
25300 shares
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
19.78
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
0 shares
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
0
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
53700 shares
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
19.95
CY2022Q1 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
25000000 USD
CY2018Q3 htld Allowable Amount For Issuanceof Lettersof Credit
AllowableAmountForIssuanceofLettersofCredit
30000000 USD
CY2022Q1 htld Allowable Amount For Issuanceof Lettersof Credit
AllowableAmountForIssuanceofLettersofCredit
20000000 USD
CY2022Q1 htld Debt Instrument Covenant Leverage Ratio
DebtInstrumentCovenantLeverageRatio
2
CY2022Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
4500000 USD
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
4700000 USD
CY2021Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.254
CY2022Q1 htld Debt Covenant Minimum Tangible Net Worth
DebtCovenantMinimumTangibleNetWorth
250000000 USD
CY2022Q1 dei Document Period End Date
DocumentPeriodEndDate
2022-03-31
CY2022Q1 us-gaap Line Of Credit
LineOfCredit
0 USD
CY2022Q1 dei Document Period End Date
DocumentPeriodEndDate
2022-03-31
CY2022Q1 dei Document Period End Date
DocumentPeriodEndDate
2022-03-31
CY2022Q1 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
8500000 USD
CY2022Q1 dei Document Period End Date
DocumentPeriodEndDate
2022-03-31
CY2022Q1 us-gaap Line Of Credit Facility Current Borrowing Capacity
LineOfCreditFacilityCurrentBorrowingCapacity
16500000 USD
CY2022Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
0 USD
CY2022Q1 dei Document Period End Date
DocumentPeriodEndDate
2022-03-31
CY2022Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.256
CY2022Q1 dei Document Period End Date
DocumentPeriodEndDate
2022-03-31
CY2022Q1 dei Document Period End Date
DocumentPeriodEndDate
2022-03-31
CY2021Q4 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
3700000 USD
CY2022Q1 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
3600000 USD
CY2022Q1 dei Document Period End Date
DocumentPeriodEndDate
2022-03-31
CY2022Q1 us-gaap Unrecognized Tax Benefits Period Increase Decrease
UnrecognizedTaxBenefitsPeriodIncreaseDecrease
200000 USD
CY2021Q1 us-gaap Unrecognized Tax Benefits Period Increase Decrease
UnrecognizedTaxBenefitsPeriodIncreaseDecrease
200000 USD
CY2022Q1 dei Document Period End Date
DocumentPeriodEndDate
2022-03-31
CY2022Q1 dei Document Period End Date
DocumentPeriodEndDate
2022-03-31
CY2022Q1 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
800000 USD
CY2022Q1 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
800000 USD
CY2021Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
800000 USD
CY2022Q1 dei Document Period End Date
DocumentPeriodEndDate
2022-03-31
CY2022Q1 dei Document Period End Date
DocumentPeriodEndDate
2022-03-31
CY2021Q1 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0 USD
CY2022Q1 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0 USD
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
4671000 USD
CY2022Q1 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
84000 USD
CY2022Q1 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
22000 USD
CY2022Q1 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
224000 USD
CY2022Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
4509000 USD
CY2022Q1 dei Document Period End Date
DocumentPeriodEndDate
2022-03-31
CY2022Q1 us-gaap Unrecorded Unconditional Purchase Obligation Balance Sheet Amount
UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount
22300000 USD
CY2022Q1 dei Document Period End Date
DocumentPeriodEndDate
2022-03-31
CY2022Q1 dei Document Period End Date
DocumentPeriodEndDate
2022-03-31

Files In Submission

Name View Source Status
0000799233-22-000022-index-headers.html Edgar Link pending
0000799233-22-000022-index.html Edgar Link pending
0000799233-22-000022.txt Edgar Link pending
0000799233-22-000022-xbrl.zip Edgar Link pending
exhibit3112022q1.htm Edgar Link pending
exhibit3122022q1.htm Edgar Link pending
exhibit3212022q1.htm Edgar Link pending
exhibit3222022q1.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
htld-20220331.htm Edgar Link pending
htld-20220331.xsd Edgar Link pending
htld-20220331_cal.xml Edgar Link unprocessable
htld-20220331_def.xml Edgar Link unprocessable
htld-20220331_htm.xml Edgar Link completed
htld-20220331_lab.xml Edgar Link unprocessable
htld-20220331_pre.xml Edgar Link unprocessable
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending